Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01118_DB05039_nanopub.RAoURAd5My757oQX-IInmoc67zQmxwMesKfm3V-0bRnAg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01118_DB05039 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01118_DB05039 label "DDI between Amiodarone and Indacaterol - Concomitant therapy with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs that prolong the QTc interval should be monitored closely. These drugs may potentiate the effect of adrenergic agonist on the cardiovascular system. [drugbank_resource:DB01118_DB05039]" assertion.
- drugbank_resource:DB01118_DB05039 identifier "drugbank_resource:DB01118_DB05039" assertion.
- drugbank_resource:DB01118_DB05039 title "DDI between Amiodarone and Indacaterol - Concomitant therapy with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs that prolong the QTc interval should be monitored closely. These drugs may potentiate the effect of adrenergic agonist on the cardiovascular system." assertion.
- drugbank:DB01118 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01118_DB05039 assertion.
- drugbank:DB05039 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01118_DB05039 assertion.